Evogene Ltd. (EVGN) stock
EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31
$0.36−0.03 (-8.70%)
Close on Nov 12, 2026Market cap $3.15MP/E 0.3Yield –
Evogene enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Evogene's enterprise value was $5.09M on Nov 11, 2026, against $16.83M a year earlier. Over the last 5 years it ranged from $2.22M to $42.14M, with a median of $16.55M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.09M | -70.4% |
| 2025 | Dec 31, 2025 | $17.18M | +1.5% |
| 2024 | Dec 31, 2024 | $16.92M | -46.5% |
| 2023 | Dec 29, 2023 | $31.64M | +275.6% |
| 2022 | Dec 30, 2022 | $8.42M | -75.3% |
| 2021 | Dec 31, 2021 | $34.11M | -66.3% |
| 2020 | Dec 31, 2020 | $101.18M | +201.2% |
| 2019 | Dec 31, 2019 | $33.59M | -29.4% |
| 2018 | Dec 31, 2018 | $47.55M | -36.6% |
| 2017 | Dec 29, 2017 | $74.99M | -37.1% |
| 2016 | Dec 30, 2016 | $119.21M | – |
See a number that looks wrong?